Infectious complications in patients randomized to receive allogeneic bone marrow or peripheral blood transplantation

Transplant Infectious Disease

Volumn 5, Issue 4, 2003, Pages 167-173

  Nucci, M ^a   Andrade, F ^b   Vigorito, A ^b   Trabasso, P ^b   Aranha, J F ^b   Maiolino, A ^a   De Souza, Cármino A ^b  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Complication; Infection; Marrow; Peripheral blood; Stem cell source

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIVIRUS AGENT; CORTICOSTEROID; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; STEROID;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANTIBIOTIC PROPHYLAXIS; CLINICAL TRIAL; DISEASE DURATION; DISEASE SEVERITY; DRUG DOSE REGIMEN; GRAFT VERSUS HOST REACTION; HOSPITALIZATION; HUMAN; INCIDENCE; INFECTIOUS COMPLICATION; MEDICAL DOCUMENTATION; MORBIDITY; MORTALITY; MULTIVARIATE ANALYSIS; NEUTROPENIA; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PNEUMOCYSTIS CARINII; PRIORITY JOURNAL; RECIPIENT; REVIEW; RISK ASSESSMENT; RISK FACTOR; ADOLESCENT; ADULT; ALLOTRANSPLANTATION; ARTICLE; BONE MARROW TRANSPLANTATION; CHILD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; INFECTION; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; CHILD; FEMALE; GRAFT VS HOST DISEASE; HUMANS; INFECTION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS;

EID: 2342471922     PISSN: 13982273     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2003.00033.x     Document Type: Review

References (38)

1. AZEVEDO WM, ARANHA FJ, GOUVEA JV et al. Allogeneic transplantation with blood stem cells mobilized by rhG-CSF for hematological malignancies. Bone Marrow Transplant 1995:16:647-653.
2. BENSINGER WI, CLIFT R, MARTIN P, et al. . Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: a retrospective comparison with marrow transplantation. Blood 1996:88:2794-2800.
3. PAVLETIC ZS, BISHOP MR, TARANTOLO SR, et al. Hematopoietic recovery after allogeneic blood stem-cell transplantation compared with bone marrow transplantation in patients with hematologic malignancies. J Clin Oncol 1997:15:1608-1616.
4. LEMOLI RM, BANDINI G, LEOPARDI G, et al. Allogeneic peripheral blood stem cell transplantation in patients with early-phase hematologic malignancy: a retrospective comparison of short-term outcome with bone marrow transplantation. Haematologica 1998:83:48-55.
5. BACIGALUPO A, ZIKOS P, VAN LINT MT, et al. Allogeneic bone marrow or peripheral blood cell transplants in adults with hematologic malignancies: a single-center experience. Exp Hematol 1998:26:409-414.
6. SCOTT MA, GANDHI MK, JESTICE HK, MAHENDRA P, BASS G, MARCUS RE. A trend towards an increased incidence of chronic graft-versus-host disease following allogeneic peripheral blood progenitor cell transplantation: a case controlled study. Bone Marrow Transplant 1998:22:273-276.
7. SOLANO C, MARTINEZ C, BRUNET S, et al. Chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell or bone marrow transplantation from matched related donors. A case-control study. Spanish Group of Allo-PBT. Bone Marrow Transplant 1998:22:1129-1135.
8. USTUN C, ARSLAN O, BEKSAC M, et al. A retrospective comparison of allogeneic peripheral blood stem cell and bone marrow transplantation results from a single center: a focus on the incidence of graft-vs.-host disease and relapse. Biol Blood Marrow Transplant 1999:5:28-35.
9. RUSSELL JA, LARRATT L, BROWN C, et al. Allogeneic blood stem cell and bone marrow transplantation for acute myelogenous leukemia and myelodysplasia: influence of stem cell source on outcome. Bone Marrow Transplant 1999:24:1177-1183.
10. POWLES R, MEHTA J, KULKARNI S, et al. Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial. Lancet 2000:355:1231-1237.
11. CHAMPLIN RE, SCHMITZ N, HOROWITZ MM, et al. Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT). Blood 2000:95:3702-3709.
12. BLAISE D, KUENTZ M, FORTANTER C, et al. Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Societe Francaise de Greffe de Moelle. J Clin Oncol 2000:18:537-546.
13. BENSINGER WI, MARTIN PJ, STOKER B, et al. Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. N Engl J Med 2001:344:175-181.
14. REMBERGER M, RINGDEN O, BLAU IW, et al. No difference in graft-versus-host disease, relapse, and survival comparing peripheral stem cells to bone marrow using unrelated donors. Blood 2001:98:1739-1745.
15. VIGORITO AC, MARQUES JUNIOR JF, ARANHA FJ, OLIVEIRA GB, MIRANDA EC, DE SOUZACA. A randomized, prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of hematologic malignancies: an update. Haematologica 2001:86:665-666.
16. GUARDIOLA P, RUNDE V, BACIGALUPO A, et al. Retrospective comparison of bone marrow and granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells for allogeneic stem cell transplantation using HLA identical sibling donors in myelodysplastic syndromes. Blood 2002:99:4370-4378.
17. SCHMITZ N, BACIGALUPO A, HASENCLEVER D, et al. Allogeneic bone marrow transplantation vs. filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 1998:21:995-1003.
18. COUBAN S, SIMPSON DR, BARNETT MJ, et al. A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies. Blood 2002:100:1525-1531.
19. MORTON J, HUTCHINS C, DURRANT S. Granulocyte-colony-stimulating factor (G-CSF)-primed allogeneic bone marrow: significantly less graft-versus-host disease and comparable engraftment to G-CSF-mobilized peripheral blood stem cells. Blood 2001:98:3186-3191.
20. SCHMITZ N, BEKSAC M, HASENCLEVER D, et al. Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemia. Blood 2002:100:761-767.
21. CUTLER C, GIRI S, JEYAPALAN S, PANIAGUA D, VISWANATHANA, ANTIN JH. Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis. J Clin Oncol 2001:19:3685-3691.
22. FLOWERS ME, PARKER PM, JOHNSTON LJ, et al. Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial. Blood 2002:100:415-419.
23. STOREK J, DAWSON MA, STORER B, et al. Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation. Blood 2001:97:3380-3389.
24. WlNGARD JR. Opportunistic infections after blood and marrow transplantation. Transpl Infect Dis 1999:1:3-20.
25. VIGORITO AC, AZEVEDO WM, MARQUES JF, et al. A randomised, prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of haematological malignancies. Bone Marrow Transplant 1998:22:1145-1151.
26. The Immunocompromised Host Society. The design, analysis, and reporting of clinical trials on the empirical antibiotic management of the neutropenic patient. Report of a consensus panel. J Infect Dis 1990:161:397-401.
27. ASCIOGLU S, REX JH, DE PAUW B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002:34:7-14.
28. Nucci M, SPECTOR N, BUENO AP, et al. Risk factors and attributable mortality associated with superinfections in neutropenic patients with cancer. Clin Infect Dis 1997:24:575-579.
29. HELDAL D,TJONNFJORD G, BRINCH L, et al. A randomised study of allogeneic transplantation with stem cells from blood or bone marrow. Bone Marrow Transplant 2000:25:1129-1136.
30. MAHMOUD H, FAHMY O, KAMEL A, KAMEL M, EL HADDAD A, EL KADI D. Peripheral blood vs. bone marrow as a source for allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 1999:24:355-358.
31. NIVISON-SMITH I, BRADSTOCK KF, SZER J, et al. Allogeneic haemopoietic cell transplants in Australia, 1996 - a multi-centre retrospective comparison of the use of peripheral blood stem cells with bone marrow. Bone Marrow Transplant 2001:28:21-27.
32. RINGDEN O, REMBERGER M, RUNDE V, et al. Faster engraftment of neutrophils and platelets with peripheral blood stem cells from unrelated donors: a comparison with marrow transplantation. Bone Marrow Transplant 2000:25 (Suppl. 2):S6-S8.
33. SERODY JS, SPARKS SD, LIN Y, et al. Comparison of granulocyte colony-stimulating factor (G-CSF) - mobilized peripheral blood progenitor cells and G-CSF-stimulated bone marrow as a source of stem cells in HLA-matched sibling transplantation. Biol Blood Marrow Transplant 2000:6:434-440.
34. HAGGLUND H, RINGDEN O, REMBERGER M, et al. Faster neutrophil and platelet engraftment, but no differences in acute GVHD or survival, using peripheral blood stem cells from related and unrelated donors, compared to bone marrow. Bone Marrow Transplant 1998:22:131-136.
35. LOKHORST HM, MEUWISSEN OJ, BAST EJ, DEKKER AW.VAD chemotherapy for refractory multiple myeloma. Br J Haematol 1989:71:25-30.
36. ANAISSIE EJ, KONTOYIANNIS DP, O'BRIEN S, et al. Infections in patients with chronic lymphocytic leukemia treated with fludarabine. Ann Intern Med 1998:129:559-566.
37. WALD A, LEISENRING W, VAN BURIKJ A, BOWDEN RA. Epidemiology of Aspergillis infections in a large cohort of patients undergoing bone marrow transplantation. J Infect Dis 1997:175:1459-1466.
38. RIBAUD P, CHASTANG C, LATGE JP, et al. Survival and prognostic factors of invasive aspergillosis after allogeneic bone marrow transplantation. Clin Infect Dis 1999:28:322-330.